InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
33%
T+90 mean return
-3.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Gutierrez-Ramos Jose-Carlos, VP Senior. Officer active across 3 companies, notably DANAHER CORP. In total, 16 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €246k. Activity tracked since 3 January 2022. The latest transaction was disclosed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations16 total
1,695 shares0Common StockSEC:0000313616-26-000054:0
1,695 shares0Common StockSEC:0000313616-26-000054
216 shares@ US$207.766.0% of flowCommon StockSEC:0000313616-25-000066:0
586 shares@ US$211.1416.3% of flowCommon StockSEC:0000313616-25-000056:0
6,250 shares0Ordinary SharesSEC:0001415889-25-000917:0
2,932 shares0Common StockSEC:0000313616-24-000100:0
866 shares@ US$253.8428.1% of flowCommon StockSEC:0000313616-24-000078:0
3,155 shares0Common StockSEC:0000313616-24-000067:0
6,000 shares0Ordinary SharesSEC:0001209191-24-000885:0
590 shares@ US$250.5418.7% of flowCommon StockSEC:0000313616-23-000246:0
500 shares@ US$242.192815.3% of flowCommon StockSEC:0000313616-23-000167:0
481 shares@ US$249.1215.6% of flowCommon StockSEC:0000313616-23-000118:0
5,750 shares0Ordinary SharesSEC:0001209191-23-002180:0
260 shares@ US$271.560.0001% mcap100.0% of flowCommon StockSEC:0000313616-22-000095:0
5,000 shares0Ordinary SharesSEC:0001209191-22-001808:0
5,000 shares0Ordinary SharesSEC:0001209191-22-001808
16 of 16 declarations
About Gutierrez-Ramos Jose-Carlos
Jose-Carlos Gutierrez-Ramos is the Chief Science Officer at Danaher Corp. and Bicycle Therapeutics plc. In this role, he is responsible for leading scientific initiatives and innovation within both companies. Jose-Carlos plays a key role in developing new technologies and solutions that support the mission of Danaher and Bicycle Therapeutics. His scientific expertise is essential in guiding research and development efforts.
